Limcer Inc is a
Ophthalmology based in Humble, Texas. Limcer Inc is licensed to practice in Texas (license number G3557) and their current practice location is
20022 Highway 59 North @ Fm 1960, Humble, Texas. It can be reached at their office (for appointments etc.) via phone at
(281) 540-2688.
NPI number for Limcer Inc is 1285934109 and their current mailing address is 20022 Highway 59 North @ Fm 1960, Humble, Texas. Limcer Inc
does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1285934109.
Healthcare Provider's Profile
| Full Name | Limcer Inc |
|---|
| Type | Facility |
|---|
| Speciality | Ophthalmology |
|---|
| Location | 20022 Highway 59 North @ Fm 1960, Humble, Texas |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
NPI Data:
- NPI Number: 1285934109
- Provider Enumeration Date: 10/26/2010
- Last Update Date: 10/26/2010
Medical Identifiers
Medical identifiers for Limcer Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1285934109 | NPI | - | NPPES |
| G3557 | Other | TX | MEDICAL LICENSE |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 152W00000X | Optometrist | 6433TG (Texas) | Secondary |
| 207W00000X | Ophthalmology | G3557 (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Limcer Inc is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Limcer Inc 20022 Highway 59 North @ Fm 1960, Humble, TX 77338 Ph: (281) 540-2688 | Limcer Inc 20022 Highway 59 North @ Fm 1960, Humble, TX 77338 Ph: (281) 540-2688 |
Reviews and Comments